Status:
COMPLETED
The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Autoimmune Diseases
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the biodistribution of a new agent 1-L-(2 deoxy-2,-18fluoroarabinofuranosyl) cytosine non-invasively in healthy humans and to evaluate whether it can be used ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- greater than 18 years of age
- women of childbearing potential will undergo a pregnancy test free of charge
- patients with hematological malignancies, solid tumors or autoimmune disorders
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01180868
Start Date
May 1 2008
Last Update
July 31 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095